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Ytterbium triflate efficiently catalyzes an unusual cyclization of o-hydroxybenzaldehydes with 2,3-dihydrofuran
and 3,4-dihydro-2H-pyran in the presence of trimethyl orthoformate at ambient temperature to afford a new class
of compounds, furo- and pyrano[2,3-b]benzopyrans in excellent yields with high diastereoselectivity. Also,
o-hydroxybenzaldehydes reacted smoothly with acetophenones in the presence of a catalytic amount of scandium
triflate under similar reaction conditions to give the corresponding 2,4-dialkoxy-2-aryl-3,4-dihydro-2H-1-
benzopyrans in high yields.
2H-1-Benzopyrans (chromenes) and 3,4-dihydro-2H-1-benzo-
pyrans (chromanes) are important classes of oxygenated hetero-
cycles that have attracted much synthetic interest because of the
biological activity of naturally occurring representatives.1,2
2-Substituted chromanes are particularly useful intermediates
for the synthesis of naphthalene and phenanthrene derivatives.3
In addition, 2-alkoxychromanes are versatile intermediates 4,5
for the synthesis of 2-oxoalkylchromanes, 2-cyanochromanes
and 2-allylchromanes. Furthermore, the fused acetal moiety is
an important structural subunit of a variety of biologically
active natural products 6,7 such as aflatoxin, clerodin, asteltoxin,
rhyacophiline, acmimycin and others. In particular, fused
tetrahydropyrano[2,3-b]benzopyran derivatives are frequently
found in naturally occurring bioactive molecules,8 and direct
methods for their synthesis are highly desired.9,10 However,
there are no reports on the synthesis of cis-fused furano-
and pyranobenzopyrans from salicylaldehydes and cyclic enol
ethers. Lanthanide triflates are unique Lewis acids that are
currently of great research interest. They are quite stable to
water and reusable as well as being highly efficient.11 Therefore,
lanthanide triflates are unique catalysts compared with con-
ventional Lewis acids in several carbon–carbon bond-forming
reactions and have found wide applications in organic synthesis.
Results and discussion
In continuation of our interest in the applications of metal tri-
flates for various transformations,12 we herein describe a new
and efficient method for the synthesis of fused chromanes using
a catalytic amount of ytterbium triflate. Treatment of salicyl-
aldehyde with 2,3-dihydrofuran and trimethyl orthoformate in
the presence of 5 mol% of Yb(OTf )3 in dichloromethane at
ambient temperature resulted in the formation of cis-fused
furano[2,3-b]benzopyran in 92% yield (Scheme 1; Table 1,
entry a).
Similarly, several salicylaldehydes reacted well to give the
corresponding fused acetals in excellent yields. In all cases, the
reactions proceeded smoothly at ambient temperature with
high selectivity. Only one diastereomer was obtained in each
reaction, the structure of which was established by detailed
NMR studies. The tetrahydropyran and tetrahydrofuran rings
are cis-fused as depicted by the coupling constant of the proton
at δ 5.84, JH3–H4 = 5.8 Hz, and the presence of a strong cross-
peak between H3–H4 in the NOESY spectrum of the product
3a. The coupling constant of the proton at δ 4.63, JH3–H5 =
5.5 Hz, and the presence of NOE cross-peaks between H3–H5
and H4–H5 indicate that these three protons are on the same
side of the six-membered ring. A boat conformation of the
ring was consistent with the experimental values of JH3–H4 and
JH3–H5, and the presence of an NOE cross-peak between the
methoxy group and the aromatic proton (H-6) permitted the
assignment of the protons in the phenyl ring, which is further
supported by molecular mechanics calculations (Fig. 1).13
Further, the reaction of salicylaldehydes with 3,4-dihydro-
2H-pyran under similar reaction conditions gave the corre-
sponding pyrano[2,3-b]benzopyran derivatives in high yields
(Scheme 2).
The reaction is highly selective, and affords exclusively cis-
fused acetals under the reaction conditions used. In the product
3b, the two six-membered rings are cis-fused, consistent with
a small coupling constant value JH4–H5 = 2.3 Hz, and strong
NOESY cross-peak between H4 and H5. The coupling con-
stant JH4–H6 = 5.5 Hz and H4–H6 cross-peaks in the NOESY
spectrum shows that H4, H5 and H6 are on the same side of
Scheme 1 Non-systematic numbering for products 3.
Scheme 2 Non-systematic numbering for products 3.
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Table 1 Yb(OTf )3-catalyzed synthesis of furo- and pyranobenzopyrans
a
Entry ortho-Hydroxy aldehyde 1 Enol ether 2 Reaction time (t/h) Yield (%) b
a 2.5 92
b 3.0 89
c 1.5 80
d 3.0 90
e 2.5 87
f 2.0 75
g 2.5 88
h 3.0 90
i 2.5 92
j 3.5 89
k 4.5 85
l 3.0 90
m 3.5 87
n 4.0 81
o 4.5 75
a All products were characterized by 1H, 13C NMR, IR and mass spectra. b Isolated and unoptimized yields. 
the six-membered ring which takes a twist conformation.
The other six-membered ring has a chair conformation (1C4)
which is supported by the presence of NOEs the between
H1ax–H3ax, H2ax–H4 and JH3ax–H4 = 12.4 Hz, JH1ax–H2ax =
11.3 Hz. The NOE cross-peak between the methoxy and aro-
matic proton (H-7) permitted the assignment of the aromatic
protons (Fig. 2).
The reaction also proceeded smoothly with the dimethyl
acetal of various salicyaldehydes and enol ethers in dichloro-
methane using 5 mol% Yb(OTf )3 at ambient temperature.
Other enol ethers, such as ethyl vinyl ether, worked well at 0 C
in the presence of 5 mol% Yb(OTf )3 and trimethyl ortho-
formate in dichloromethane to afford the corresponding
2-ethoxy-4-methoxychromane in 80% yield with high selectivity
(Scheme 3; Table 1, entry c).
In this product 3c, the six membered ring behaved like the
earlier products; the almost equal values of couplings JH2a–H3 =
7.4 Hz and JH2b–H3 = 5.9 Hz are consistent with a twist conform-
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ation for the six-membered ring, which is further supported by
molecular mechanics calculations (Fig. 3).
Several examples illustrating this novel and rapid procedure
for the synthesis of fused chromanes are summarized in Table 1.
Furthermore, the treatment of salicylaldehyde with aceto-
phenone and trimethyl orthoformate in the presence of 5%
Sc(OTf )3 at ambient temperature resulted in the formation
of 2,4-dimethoxy-2-phenylchromane in 85% yield (Scheme 4;
Table 2, entry a).
Several salicylaldehydes reacted well with acetophenones
under the present rection conditions to afford the corre-
sponding 2-alkoxychromanes in high yields. In all cases,
Fig. 1 Important NOE interactions and energy-minimized structure
of 3a. Non-systematic numbering.
Fig. 2 Important NOE interactions and energy-minimized structure
of 3b. Non-systematic numbering.
Scheme 3
Scheme 4
the reactions proceeded smoothly at ambient temperature
with high diastereoselectivity. Only a single diastereomer
was obtained in each reaction, the structure of which was
established by 1H NMR studies. The assigned structure was
further confirmed by direct comparison with literature data.10
However, ketones such as cyclohexanone, cyclopentanone and
tetralone did not yield any condensation products under these
reaction conditions. The reaction was successful only with
acetophenones and salicylaldehydes. Aliphatic aldehydes failed
to react with acetophenones under the present reaction
conditions. Several examples illustrating this new and novel
method for the synthesis of 2-alkoxychromanes are listed
in Table 2. This synthetic protocol utilizes readily available
starting materials and a reusable catalyst, i.e., scandium triflate.
The reaction may proceed through the formation of ortho-
quinonemethides generated in situ from salicylaldehydes and
trimethyl orthoformate (TMOF) as shown in Scheme 5.
The experimental procedure is very simple and the products
are obtained in excellent yields with high diastereoselectivity.
The reaction conditions are very mild and no side products or
decomposition of the products are observed. The reactions are
clean and are completed in a short reaction time. The catalyst
was recovered from the aqueous layer during work-up and
recycled in subsequent reactions without reduction in activity.
In summary, this paper describes a new method for the syn-
thesis of fused chromanes from salicylaldehydes and enol ethers
using a catalytic amount of Yb(OTf )3. It also describes a
method for the synthesis of 2,4-dimethoxy-2-arylchromanes by
the cyclocondensation of salicylaldehydes with acetophenones
using a catalytic amount of Sc(OTf )3 under similar conditions.
In addition to its efficiency, simplicity and milder reaction
conditions, this method provides high yields of products with
diastereoselectivity, which makes it a useful process for the
synthesis of cis-fused chromanes and 2-alkoxychromanes.
Fig. 3 Important NOE interactions and energy-minimized structure
of 3c. Non-systematic numbering.
Scheme 5
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Table 2 Sc(OTf )3-catalyzed synthesis of 2,4-dialkoxy-2-arylchromanes
a
Entry o-Hydroxybenzaldehyde 1 Aryl ketone 2 Time (t/h) Yield b (%)
a 6.5 85
b 5.0 81
c 9.0 78
d 8.0 85
e 7.5 88
f 9.5 75
g 7.0 80
h 6.5 84
i 8.0 76
j 6.5 80
k 7.0 85
l 8.0 77
m 7.5 82
n 9.0 75
o 9.5 73
a All products were characterized by 1H NMR, IR and mass spectra. b Isolated and unoptimized yields. 
168 J. Chem. Soc., Perkin Trans. 1, 2002, 165–171
D
ow
nl
oa
de
d 
on
 0
8 
O
ct
ob
er
 2
01
1
Pu
bl
ish
ed
 o
n 
21
 D
ec
em
be
r 2
00
1 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/B1
095
38M
View Online
Experimental
General
All melting points were determined using a Buchi R-535
apparatus. Proton magnetic resonance (1H NMR) and carbon
magnetic resonance (13C NMR) spectra were recorded on a
Varian Gemini 200,500 MHz spectrometer. IR spectra were
recorded on a Perkin-Elmer Infrared-683 spectrometer. Mass
spectra were recorded on either a Finnigan-MAT1020B or
Micro Mass VG70-70H. Elemental analysis was done on an
Elementar Vario EL. Column chromatography was performed
on silica gel (100–200 mesh); hexane was used as a co-eluent.
Anhydrous sodium sulfate was used as drying agent for the
organic extracts. Solvent removal was achieved by using a Buchi
rotary evaporator.
I Preparation of cis-fused pyrano- and furanochromanes
A mixture of salicylaldehyde (5 mmol), trimethyl orthoformate
(6 mmol) and Yb(OTf )3 (5 mol% in dichloromethane; 10 mL)
was stirred at ambient temperature for 10–15 min. Then a
cyclic enol ether (7.5 mmol) was added slowly at 0 C to the
above mixture. The resulting reaction mixture was stirred at
ambient temperature for an appropriate time. After complete
conversion as indicated by TLC, the reaction mixture was
quenched with water (10 mL) and extracted with dichloro-
methane (2 × 15 mL). The combined extracts were dried over
anhydrous Na2SO4, concentrated in vacuo, and purified by
column chromatography on silica gel (Merck, 100–200 mesh;
ethyl acetate–hexane, 1 : 9) to afford pure cis-fused acetal
(Table 1, 3a–3o).
Compound 3a. 4-Methoxy-2,3,3a,9a-tetrahydro-4H-furo-
[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz) δ 1.70
(dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.93 (dddd, 1H, J = 5.0,
7.6, 9.2, 12.7 Hz), 3.17 (dt, 1H, J = 5.5, 5.8, 9.2 Hz), 3.60 (s, 3H),
3.80 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.85 (dt, 1H, J = 7.5, 7.6,
8.5 Hz), 4.63 (d, 1H, J = 5.5 Hz), 5.84 (d, 1H, J = 5.8 Hz), 6.88
(dd, 1H, H9, J = 1.3, 8.0 Hz), 6.99 (dt, 1H, H7, J = 1.3, 7.4 Hz),
7.18 (dt, 1H, H8, J = 2.3, 7.9 Hz), 7.42 (td, 1H, H6, J = 1.5,
7.5 Hz).
13C NMR (proton decoupled 13C in CDCl3, at 50 MHz)
δ 23.92, 42.29, 56.87, 68.18, 73.75, 102.26, 116.68, 121.56,
124.72, 125.46, 128.42, 152.15; EIMS: m/z 206 (M) [Calc.
for C12H14O3 (206.24): C, 69.89; H, 6.84. Found: C, 69.92; H,
6.87%].
Compound 3b. 5-Methoxy-3,4,4a,10a-tetrahydro-2H,5H-
pyrano[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz)
δ 1.33 (m, 1H, H3ax), 1.63 (m, 1H, H2eq), 1.68 (m, 1H, H3eq), 1.77
(m, 1H, H2ax), 2.49 (dddd, 1H, J = 2.3, 3.8, 5.5, 12.4 Hz), 3.54
(s, 3H), 3.77 (dddd, 1H, H1eq, J = 1.5, 4.8, 11.3 Hz), 4.02 (dt,
1H, H1ax, J = 2.7, 11.3 Hz), 4.58 (d, 1H, J = 5.5 Hz), 5.48 (d, 1H,
J = 2.3 Hz), 6.85 (dd, 1H, H10, J = 1.3, 8.1 Hz), 6.93 (dt, 1H, H8,
J = 1.2, 7.4 Hz), 7.17 (dt, 1H, H9 J = 1.6, 8.1 Hz), 7.40 (td, 1H,
H7, J = 1.5, 7.6 Hz); 13C NMR (proton decoupled 13C in CDCl3;
50 MHz) δ 16.56, 23.99, 34.56, 56.58, 61.02, 75.70, 95.79,
115.66, 120.78, 121.34, 126.58, 151.86; EIMS: m/z 220 (M)
[Calc. for C13H16O3 (220.266): C, 70.89; H, 7.32. Found: C,
70.93; H, 7.35%].
Compound 3c. 2-Ethoxy-4-methoxychromane. Liquid, 1H
NMR (CDCl3) δ 1.25 (t, 3H, J = 7.1 Hz), 2.17 (dt, 1H, J = 6.9,
13.3 Hz), 2.37 (dddd, 1H, J = 2.7, 6.0, 13.3 Hz), 3.46 (s, 3H),
3.66 (dq, 1H, J = 7.1, 9.7 Hz), 3.99 (dq, 1H, J = 7.1, 9.7 Hz),
4.54 (dd, 1H, J = 6.0, 7.4 Hz), 5.21 (dd, 1H, J = 2.8, 6.9 Hz),
6.85 (dd, 1H, H7, J = 1.3, 8.1 Hz), 6.95 (dt, 1H, H5, J = 1.3,
7.5 Hz), 7.19 (dt, 1H, H6, J = 1.9, 7.6 Hz), 7.36 (dd, 1H, H4,
J = 2.3, 7.6 Hz); 13C NMR (proton decoupled 13C in CDCl3;
50 MHz) δ 14.97, 32.75, 55.68, 64.34, 71.79, 97.85, 116.88,
120.88, 123.20, 128.05, 129.08, 152.12; EIMS: m/z 208 (M)
[Calc. for C12H16O3 (208.255): C, 69.21; H, 7.74 Found: C,
69.25; H, 7.75%].
Compound 3d. 4,8-Dimethoxy-2,3,3a,9a-tetrahydro-4H-furo-
[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz) δ 1.75
(dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.90 (dddd, 1H, J = 5.0,
7.6, 9.2, 12.7 Hz), 3.18 (dt, 1H, J = 5.5, 5.8, 9.2 Hz), 3.60 (s, 3H)
3.78 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.83 (dt, 1H, J = 7.5, 7.6, 8.5
Hz), 3.85 (s, 3H), 4.60 (d, 1H, J = 5.5 Hz), 5.85 (d, 1H, J = 5.8
Hz), 6.80 (d, 1H, H, J = 8.0 Hz), 6.90 (t, 1H, J = 7.4 Hz), 6.98
(d, 1H, J = 7.9 Hz); EIMS: m/z 236 (M) [Calc. for C13H16O4
(236.265): C, 66.09; H, 6.83. Found: C, 66.12; H, 6.87%].
Compound 3e. 5,9-Dimethoxy-3,4,4a,10a-tetrahydro-2H,5H-
pyrano[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz)
δ 1.35 (m, 1H, H3ax), 1.65 (m, 1H, H2eq), 1.67 (m, 1H, H3eq), 1.78
(m, 1H, H2ax), 2.45 (dddd, 1H, J = 2.3, 3.8, 5.5, 12.4 Hz), 3.54
(s, 3H), 3.75 (dddd, 1H, H1eq, J = 1.5, 4.8, 11.3 Hz), 3.85 (s,
3H), 4.05 (dt, 1H, H1ax, J = 2.7, 11.3 Hz), 4.58 (d, 1H, J =
5.5 Hz), 5.5 (d, 1H, J = 2.3 Hz), 6.78 (d, 1H, J = 8.1 Hz), 6.83
(t, 1H, J = 7.4 Hz), 6.98 (d, 1H, J = 8.1 Hz); EIMS: m/z 250
(M) [Calc. for C14H18O4 (250.292): C, 67.18; H, 7.25. Found:
C, 67.15; H, 7.28%].
Compound 3f. 2-Ethoxy-4,8-dimethoxychromane. Liquid, 1H
NMR (CDCl3) δ 1.25 (t, 3H, J = 7.1 Hz), 2.18 (dt, 1H, J = 6.9
and 13.3 Hz), 2.38 (dddd, 1H, J = 2.7, 6.0, 13.3), 3.45 (s, 3H),
3.68 (dq, 1H, J = 7.1, 9.7 Hz), 3.85 (s, 3H), 3.99 (dq, 1H, J = 7.1,
9.7 Hz), 4.55 (dd, 1H, J = 6.0, 7.4 Hz), 5.23 (dd, 1H, J = 2.8, 6.9
Hz), 6.80 (d, 1H, J = 8.0 Hz); 6.85 (t, 1H, J = 7.5 Hz), 6.98 (d,
1H, J = 8.0 Hz); EIMS: m/z 238 (M) [Calc. for C13H18O4
(238.281): C, 65.53; H, 7.61. Found: C, 65.55; H, 7.63%].
Compound 3g. 8-Ethoxy-4-methoxy-2,3,3a,9a-tetrahydro-4H-
furo[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz), δ
1.40 (t, 3H, J = 6.8 Hz), 1.68 (dddd, 1H, J = 7.2, 8.6, 9.2, 12.7
Hz), 1.85 (dddd, 1H, J = 5.0, 7.6, 9.2, 12.7 Hz), 3.18 (dt, 1H, J =
5.5, 5.8, 9.2 Hz), 3.57 (s, 3H), 3.75 (dt, 1H, J = 5.0, 8.5, 8.6 Hz),
3.85 (dt, 1H, J = 7.5, 7.6, 8.5 Hz), 4.10 (q, 2H, J = 7.0 Hz), 4.58
(d, 1H, J = 5.5 Hz), 5.85 (d, 1H, J = 5.8 Hz), 6.78 (d, 1H, J = 8.0
Hz), 6.85 (t, 1H, J = 7.4 Hz), 7.0 (d, 1H, J = 7.9 Hz); EIMS: m/z
250 (M) [Calc. for C14H18O4 (250.292): C, 67.18; H, 7.25.
Found: C, 67.18; H, 7.24%].
Compound 3h. 9-Ethoxy-5-methoxy-3,4,4a,10a-tetrahydro-
2H,5H-pyrano[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500
MHz) δ 1.35 (m, 1H, H3ax), 1.40 (t, 3H, J = 7.0 Hz), 1.62 (m, 1H,
H2eq), 1.70 (m, 1H, H3eq), 1.75 (m, 1H, H2ax), 2.45 (dddd, 1H, J =
2.3, 3.8, 5.5, 12.4 Hz), 3.55 (s, 3H), 3.78 (dddd, 1H, H1eq, J = 1.5,
4.8, 11.3 Hz), 4.02 (dt, 1H, H1ax, J = 2.7, 11.3 Hz), 4.10 (q, 2H,
J = 6.9 Hz), 4.59 (d, 1H, J = 5.5 Hz), 5.48 (d, 1H, J = 2.3 Hz),
6.78 (d, 1H, J = 8.0 Hz), 6.83 (t, 1H, J = 7.5 Hz), 6.98 (d, 1H,
J = 8.1 Hz); EIMS: m/z 264 (M) [Calc. for C15H20O4 (264.319):
C, 68.16; H, 7.63. Found: C, 68.19; H, 7.65%].
Compound 3i. 4,6-Dimethoxy-2,3,3a,9a-tetrahydro-4H-furo-
[2,3-b]chromene. Liquid, 1H NMR (CDCl3; at 500 MHz) δ 1.65
(dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.87 (dddd, 1H, J = 5.0,
7.6, 9.2, 12.7 Hz), 3.18 (dt, 1H, J = 5.5, 5.8, 9.2 Hz), 3.58 (s, 3H),
3.70 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.78 (dt, 1H, J = 7.5, 7.6, 8.5
Hz), 3.80 (s, 3H), 4.50 (d, 1H, J = 5.5 Hz), 5.78 (d, 1H, J = 5.8
Hz), 6.70 (dd, 1H, J = 1.3, 8.0 Hz), 6.80 (d, 1H, J = 8.0 Hz), 6.95
(d, 1H, J = 2.3 Hz); EIMS: m/z 236 (M) [Calc. for C13H16O4
(236.265): C, 66.09; H, 6.83. Found: C, 66.12; H, 6.87%].
Compound 3j. 5,7-Dimethoxy-3,4,4a,10a-tetrahydro-2H,5H-
pyrano[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz)
δ 1.32 (m, 1H, H3ax), 1.65 (m, 1H, H2eq), 1.68 (m, 1H, H3eq), 1.77
(m, 1H, H2ax), 2.45 (dddd, 1H, J = 2.3, 3.8, 5.5, 12.4), 3.55 (s,
3H), 3.77 (dddd, 1H, H1eq, J = 1.5, 4.8, 11.3 Hz), 3.80 (s, 3H),
J. Chem. Soc., Perkin Trans. 1, 2002, 165–171 169
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4.0 (dt, 1H, H1ax, J = 2.7, 11.3 Hz), 4.58 (d, 1H, J = 5.5 Hz), 5.40
(d, 1H, J = 2.3 Hz), 6.68 (dd, 1H, J = 1.3, 8.0 Hz), 6.80 (d, 1H,
J = 8.0 Hz), 6.90 (d, 1H, J = 2.4 Hz); EIMS: m/z 250 (M) [Calc.
for C14H18O4 (250.292): C, 67.18; H, 7.25. Found: C, 67.15; H,
7.28%].
Compound 3k. 4,6-Dimethoxy-8-nitro-2,3,3a,9a-tetrahydro-
4H-furo[2,3-b]chromene. Liquid, 1H NMR (CDCl3; at 500
MHz) δ 1.68 (dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.90 (dddd,
1H, J = 5.0, 7.6, 9.2, 12.7 Hz), 3.18 (dt, 1H, J = 5.5, 5.8, 9.2 Hz),
3.59 (s, 3H), 3.78 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.80 (s, 3H), 3.85
(dt, 1H, J = 7.5, 7.6, 8.5 Hz), 4.62 (d, 1H, J = 5.5 Hz), 5.84 (d,
1H, J = 5.8 Hz), 7.18 (d, 1H, J = 2.3 Hz), 7.25 (d, 1H, J = 1.8
Hz); EIMS: m/z 281 (M) [Calc. for C13H15NO6 (281.262): C,
55.52; H, 5.38; N, 4.98. Found: C, 55.50; H, 5.41; N, 4.80%].
Compound 3l. 6-Benzyloxy-4-methoxy-2,3,3a,9a-tetrahydro-
4H-furo[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500 MHz) δ
1.69 (dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.88 (dddd, 1H, J =
5.0, 7.6, 9.2, 12.7 Hz), 3.18 (dt, 1H, J = 5.5, 5.8, 9.2 Hz), 3.57 (s,
3H), 3.75 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.80 (dt, 1H, J = 7.5, 7.6,
8.5 Hz), 4.56 (d, 1H, J = 5.5 Hz), 5.0 (s, 2H), 5.80 (d, 1H, J = 5.8
Hz), 6.80 (m, 2H), 7.05 (d, 1H, J = 1.7 Hz), 7.32–7.45 (m, 5H);
EIMS: m/z 312 (M) [Calc. for C19H20O4 (312.363): C, 73.06; H,
6.45. Found: C, 73.10; H, 6.43%].
Compound 3m. 7-Benzyloxy-5-methoxy-3,4,4a,10a-tetra-
hydro-2H,5H-pyrano[2,3-b]chromene. Liquid, 1H NMR (CDCl3;
500 MHz) δ 1.35 (m, 1H, H3ax), 1.66 (m, 1H, H2eq), 1.68 (m,
1H, H3eq), 1.78 (m, 1H, H2ax), 2.50 (dddd, 1H, J = 2.3, 3.8,
5.5, 12.4 Hz), 3.54 (s, 3H), 3.77 (dddd, 1H, H1eq, J = 1.5, 4.8,
11.3 Hz), 4.05 (dt, 1H, H1ax, J = 2.7, 11.3 Hz), 4.58 (d, 1H,
J = 5.5 Hz), 5.48 (d, 1H, J = 2.3 Hz), 6.85 (m, 2H), 7.02 (d, 1H,
J = 1.7 Hz), 7.35–7.48 (m 5H); EIMS: m/z 326 (M) [Calc. for
C20H22O4 (326.39): C, 73.6; H, 6.79. Found: C, 73.68; H, 6.81%].
Compound 3n. 11-Methoxy-9,10,10a,11-tetrahydro-7aH-
benzo[ f ]furo[2,3-b]chromene. Liquid, 1H NMR (CDCl3; 500
MHz) δ 1.70 (dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.95 (dddd,
1H, J = 5.0, 7.6, 9.2, 12.7 Hz), 3.17 (dt, 1H, J = 5.5, 5.8, 9.2 Hz),
3.55 (s, 3H), 3.80 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.85 (dt, 1H,
J = 7.5, 7.6, 8.5 Hz), 4.65 (d, 1H, J = 5.5 Hz), 5.80 (d, 1H, J =
5.8 Hz), 7.02 (d, 1H, J = 8.0 Hz), 7.30 (t, 1H, J = 7.5 Hz), 7.45
(t, 1H, J = 7.5 Hz), 7.70 (m, 2H), 7.88 (d, 1H, J = 8.0 Hz);
EIMS: m/z 256 (M) [Calc. for C16H16O3 (256.299): C, 74.98;
H, 6.29. Found: C, 75.05; H, 6.30%].
Compound 3o. 6-Bromo-4-methoxy-2,3,3a,9a-tetrahydro-4H-
furo[2,3-b]chromene. Liquid, 1H NMR (CDCl3; at 500 MHz)
δ 1.67 (dddd, 1H, J = 7.2, 8.6, 9.2, 12.7 Hz), 1.95 (dddd, 1H,
J = 5.0, 7.6, 9.2, 12.7 Hz), 3.17 (dt, 1H, J = 5.5, 5.8, 9.2 Hz), 3.57
(s, 3H), 3.80 (dt, 1H, J = 5.0, 8.5, 8.6 Hz), 3.85 (dt, 1H, J = 7.5,
7.6, 8.5 Hz), 4.58 (d, 1H, J = 5.5 Hz), 5.80 (d, 1H, J = 5.8 Hz),
6.80 (dd, 1H, J = 1.3, 8.0 Hz), 7.10 (d, 1H, J = 7.9 Hz), 7.38 (d,
1H, J = 2.3 Hz); EIMS m/z 285 (M) [Calc. for C12H13BrO3
(285.136): C, 50.55; H, 4.60; Br, 28.02. Found: C, 50.60; H, 4.57;
Br, 28.10%].
II Preparation of 2,4-dimethoxy-2-arylchromanes
A mixture of a salicylaldehyde (2 mmol), an acetophenone (2
mmol), trimethyl orthoformate (5 mmol) and scandium triflate
(5% w/w of aldehyde) in dichloromethane (10 mL) was stirred
at ambient temperature for an appropriate time (Table 2). After
complete conversion as indicated by TLC, the reaction mixture
was quenched with water (15 mL) and extracted with dichloro-
methane (2 × 10 mL). The combined organic layers were dried
over anhydrous Na2SO4, concentrated in vacuo, and purified by
column chromatography on silica gel (Merck 100–200 mesh;
ethyl acetate–hexane, 0.5 : 95) to afford pure 2,4-dimethoxy-2-
phenylchromane (Table 2, 4a–4o).
Compound 4a. 2,4-Dimethoxy-2-phenylchromane. Liquid, 1H
NMR (CDCl3) δ 1.90 (dd, 1H, J = 12.5, 10.8 Hz), 2.68 (dd,
1H, J = 12.5, 6.0 Hz), 3.10 (s, 3H), 3.50 (s, 3H), 4.90 (dd, 1H,
J = 10.8, 6.0 Hz), 6.98–7.08 (m, 2H), 7.18–7.30 (m, 1H), 7.38–
7.60 (m, 4H), 7.65 (d, 2H, J = 8.0 Hz). EIMS: m/z 270 (M),
238, 207, 161, 121, 107, 77; IR (KBr) ν/cm1 3046, 2938, 2830,
1576, 1446, 1223, 1084, 1015, 930, 745 [Calc. for C17H18O3
(270.326): C, 75.53; H, 6.71. Found: C, 75.70; H, 6.83%].
Compound 4b. 2,4,8-Trimethoxy-2-phenylchromane. Liquid,
1H NMR (CDCl3) δ 1.87 (dd, 1H, J = 12.7, 6.1 Hz), 2.67 (dd,
1H, J = 12.7, 10.6 Hz), 3.08 (s, 3H), 3.48 (s, 3H), 3.90 (s, 3H),
4.87 (dd, 1H, J = 10.6, 6.1 Hz), 5.85 (d, 1H, J = 8.0 Hz), 6.93
(t, 1H, J = 7.8 Hz), 7.10 (d, 1H, J = 8.0 Hz), 7.38–7.45
(m, 3H), 7.68 (d, 2H, J = 8.0 Hz); EIMS: m/z 300 (M), 237,
191, 151, 137, 105, 77; IR (KBr) ν/cm1 3053, 2853, 2830, 1584,
1476, 1353, 1261, 1076, 961, 730 [Calc. for C18H20O4 (300.352):
C, 71.98; H, 6.71. Found: C, 72.05; H, 6.79%].
Compound 4c. 2,4-Dimethoxy-2-(2-naphthyl)chromane.
Liquid, 1H NMR (CDCl3) δ 1.98 (dd, 1H, J = 12.8, 10.5 Hz),
2.75 (dd, 1H, J = 12.8, 6.3 Hz), 3.09 (s, 3H), 3.47 (s, 3H), 4.90
(dd, 1H, J = 10.5, 6.3 Hz), 7.05 (t, 2H, J = 7.8 Hz), 7.10 (t, 1H,
J = 7.8 Hz), 7.43–7.57 (m, 3H), 7.65 (d, 1H, J = 8.0 Hz), 7.83–
7.97 (m, 3H), 8.15 (d, 1H, J = 1.8 Hz); EIMS: m/z 320 (M),
288, 257, 184, 155, 141, 119, 77, 43; IR (KBr) ν/cm1 3061, 2930,
2838, 1630, 1446, 1338, 1207, 1030, 907, 738 [Calc. for C21H20O3
(320.386): C, 78.73; H, 6.29. Found: C, 78.77; H, 6.31%].
Compound 4d. 6-Chloro-2,4-dimethoxy-2-phenylchromane.
Solid, mp 77–79 C; 1H NMR (CDCl3) δ 1.80 (dd, 1H, J = 12.8,
10.7 Hz), 2.63 (dd, 1H, J = 12.8, 6.0 Hz), 3.05 (s, 3H), 3.45 (s,
3H), 4.80 (dd, 1H, J = 10.7, 6.0 Hz), 6.90 (d, 1H, J = 8.0 Hz),
7.18 (d, 1H, J = 8.0 Hz), 7.37–7.45 (m, 4H), 7.58 (d, 2H, J =
8 Hz); EIMS: m/z 304 (M), 272, 242, 195, 170, 155, 141, 105,
77, 43; IR (KBr) ν/cm1 3030, 3000, 2807, 1469, 1230, 1092,
1015, 900, 753 [Calc. for C17H17ClO3 (304.771): C, 67.0; H, 5.62;
Cl, 11.63. Found: C, 67.07; H, 5.68; Cl, 11.70%].
Compund 4e. 2-(4-Bromophenyl)-6-chloro-2,4-dimethoxy-
chromane. Solid, mp 117–118 C; 1H NMR (CDCl3) δ 1.78 (dd,
1H, J = 12.7, 10.8 Hz), 2.60 (dd, 1H, J = 12.7, 6.1 Hz), 3.03
(s, 3H), 3.48 (s, 3H), 4.78 (dd, 1H, J = 10.8, 6.1 Hz), 6.90 (d, 1H,
J = 7.9 Hz), 7.18 (dd, 1H, J = 7.9, 2.7 Hz), 7.50–7.60 (m, 5H);
EIMS: m/z 383 (M), 352, 321, 195, 155, 141, 102, 75, 43;
IR (KBr) ν/cm1 2969, 2923, 2023, 1576, 1476, 1246, 1092,
1046, 915, 815 [Calc. for C17H16BrClO3 (383.667): C, 53.22;
H, 4.20; Br, 20.83; Cl, 9.24. Found: C, 53.25; H, 4.27; Br, 20.89;
Cl, 9.28%].
Compound 4f. 8-Ethoxy-2,4-dimethoxy-2-(2-naphthyl)-
chromane. Liquid, 1H NMR (CDCl3) δ 1.40 (t, 3H, J = 6.8 Hz),
1.98 (dd, 1H, J = 12.8, 10.9 Hz), 2.80 (dd, 1H, J = 12.8, 6.2 Hz),
3.17 (s, 3H), 3.48 (s, 3H), 4.20 (q, 2H, J = 6.8 Hz), 4.95 (dd, 1H,
J = 10.9, 6.2 Hz), 6.90 (d, 1H, J = 8.0 Hz), 6.98 (t, 1H, J =
8.0 Hz), 7.18 (d, 1H, J = 8.0 Hz), 7.53–7.60 (m, 2H), 7.73 (d,
1H, J = 8.0 Hz), 7.85–7.98 (m, 3H), 8.20 (d, 1H, J = 1.8 Hz);
EIMS: m/z 364 (M), 170, 155, 127, 101, 77, 43; IR (KBr)
ν/cm1 3046, 2915, 2815, 1461, 1346, 1269, 1184, 1061, 1030,
815, 738 [Calc. for C23H24O4 (364.439): C, 75.80; H, 6.64.
Found: C, 76.05; H, 6.67%].
Compound 4g. 2,4-Dimethoxy-2-(4-methoxyphenyl)chromane.
Liquid, 1H NMR (CDCl3) δ 1.80 (dd, 1H, J = 12.5, 10.5 Hz),
2.60 (dd, 1H, J = 12.5, 6.2 Hz), 3.02 (s, 3H), 3.45 (s, 3H), 3.80
(s, 3H), 4.80 (dd, 1H, J = 10.5, 6.2 Hz), 6.90–7.0 (m, 4H), 7.20
(t, 1H, J = 7.8 Hz), 7.43–7.57 (m, 3H); EIMS: m/z 300 (M),
170 J. Chem. Soc., Perkin Trans. 1, 2002, 165–171
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272, 241, 167, 137, 109, 77, 43; IR (KBr) ν/cm1 3007, 2938,
2830, 2046, 1907, 1600, 1507, 1238, 1153, 1005, 892 [Calc. for
C18H20O4 (300.352): C, 71.98; H, 6.71. Found: C, 72.0; H,
6.75%].
Compound 4h. 2,4-Dimethoxy-2-(4-methylphenyl)chromane.
Solid, mp 46–47 C; 1H NMR (CDCl3) δ 1.90 (dd, 1H, J = 12.8,
11.0 Hz), 2.40 (s, 3H), 2.75 (dd, 1H, J = 12.8, 6.3 Hz), 3.10 (s,
3H), 3.50 (s, 3H), 4.90 (dd, 1H, J = 11.0, 6.3 Hz), 7.05 (t, 2H, J =
7.8 Hz), 7.25–7.38 (m, 3H), 7.50–7.60 (m, 3H); EIMS: m/z 284
(M), 254, 222, 162, 137, 108, 91, 77, 43; IR (KBr) ν/cm1 3030,
2923, 2815, 1576, 1446, 1307, 1238, 1092, 1015, 907, 753 [Calc.
for C18H20O3 (284.353): C, 76.03; H, 7.09. Found: C, 76.08;
H, 7.15%].
Compound 4i. 2-(4-Bromophenyl)-2,4-dimethoxychromane.
Liquid, 1H NMR (CDCl3) δ 1.80 (dd, 1H, J = 13.0, 10.8 Hz),
2.60 (dd, 1H, J = 13.0, 6.0 Hz), 3.05 (s, 3H), 3.43 (s, 3H), 4.80
(dd, 1H, J = 10.8, 6.0 Hz), 6.95–7.05 (m, 3H), 7.20 (t, 1H, J =
7.8 Hz), 7.40–7.55 (m, 4H); EIMS: m/z 350 (M), 322, 293,
204, 187, 158, 139, 109, 77, 43; IR (KBr) ν/cm1 3046, 2923,
2807, 1676, 1576, 1484, 1353, 1230, 1023, 900, 746 [Calc. for
C17H17BrO3 (349.222): C, 58.47; H, 4.91; Br, 22.88. Found: C,
58.5; H, 4.89; Br, 22.90%].
Compound 4j. 6-Benzyloxy-2,4-dimethoxy-2-phenylchromane.
Liquid, 1H NMR (CDCl3) δ 1.90 (dd, 1H, J = 12.8, 11.0 Hz),
2.70 (dd, 1H, J = 12.8, 6.1 Hz), 3.10 (s, 3H), 3.50 (s, 3H), 4.85
(dd, 1H, J = 11.0, 6.1 Hz), 5.08 (s, 2H), 6.90–6.95 (m, 2H), 7.18
(d, 1H, J = 2.0 Hz), 7.38–7.60 (m, 8H), 7.65 (d, 2H, J = 8.0 Hz);
EIMS: m/z 376 (M), 261, 139, 108, 79, 43; IR (KBr) ν/cm1
3015, 2923, 2830, 1607, 1484, 1200, 1146, 1015, 938, 700 [Calc.
for C24H24O4 (376.45): C, 76.57; H, 6.43. Found: C, 76.6; H,
6.51%].
Compound 4k. 2,4-Dimethoxy-2-(2-thienyl)chromane. Liquid,
1H NMR (CDCl3) δ 2.18 (dd, 1H, J = 12.9, 10.7 Hz), 2.80 (dd,
1H, J = 12.9, 6.2 Hz), 3.20 (s, 3H), 3.52 (s, 3H), 4.85 (dd, 1H, J =
10.7, 6.2 Hz), 6.98–7.10 (m, 3H), 7.20–7.30 (m, 2H), 7.35 (d,
1H, J = 8.0 Hz), 7.50 (d, 1H, J = 8.0 Hz); EIMS: m/z 276 (M),
244, 213, 136, 121, 107, 77, 65, 39; IR (KBr) ν/cm1 2969, 2930,
2807, 1576, 1446, 1346, 1200, 1146, 1084, 1030, 915 [Calc. for
C15H16O3S (276.348): C, 65.19; H, 5.84; S, 11.60. Found: C,
65.23; H, 5.85; S, 11.63%].
Compound 4l. 8-Ethoxy-2,4-dimethoxy-2-phenylchromane.
Solid, mp 83–86 C; 1H NMR (CDCl3) δ 1.45 (t, 3H, J =
6.7 Hz), 1.90 (dd, 1H, J = 13.0, 11.0 Hz), 2.70 (dd, 1H, J = 13.0,
6.5 Hz), 3.02 (s, 3H), 3.40 (s, 3H), 4.10 (q, 2H, J = 6.7 Hz), 4.80
(dd, 1H, J = 11.0, 6.5 Hz), 6.85 (d, 1H, J = 8.1 Hz), 6.90 (t, 1H,
J = 8.0 Hz), 7.05 (d, 1H, J = 8.1 Hz), 7.38–7.55 (m, 3H), 7.60 (d,
2H, J = 8.0 Hz); EIMS: m/z 314 (M), 282, 251, 165, 137, 120,
105, 91, 77, 51; IR (KBr) ν/cm1 3038, 2969, 2923, 2800, 1576,
1469, 1353, 1261, 1076, 1030, 892 [Calc. for C19H22O4 (314.379):
C, 72.59; H, 7.05. Found: C, 72.60; H, 7.10%].
Compound 4m. 6-Chloro-2,4-dimethoxy-2-(4-methylphenyl)-
chromane. Liquid, 1H NMR (CDCl3) δ 1.78 (dd, 1H, J = 12.9,
10.7 Hz), 2.40 (s, 3H), 2.60 (dd, 1H, J = 12.9, 6.2 Hz), 3.05
(s, 3H), 3.45 (s, 3H), 4.80 (dd, 1H, J = 10.7, 6.2 Hz), 6.90 (d,
1H, J = 8.0 Hz), 7.18–7.25 (m, 3H), 7.37–7.48 (m, 3H); EIMS:
m/z 318 (M), 286, 255, 195, 155, 133, 119, 91, 65, 35; IR (KBr)
ν/cm1 3023, 2930, 2823, 1669, 1469, 1230, 1092, 1038, 907, 815,
753 [Calc. for C18H19ClO3 (318.798): C, 67.82; H, 6.01; Cl,
11.12. Found: C, 67.85; H, 6.05; Cl, 11.17%].
Compound 4n. 2-(3,4-Dimethoxyphenyl)-2,4-dimethoxy-
chromane. Liquid. 1H NMR (CDCl3) δ 1.85 (dd, 1H, J = 12.7,
10.5 Hz), 2.63 (dd, 1H, J = 12.7, 6.1 Hz), 3.18 (s, 3H), 3.48 (s,
3H), 3.95 (s, 6H), 4.85 (dd, 1H, J = 10.5, 6.1 Hz), 6.85–7.05 (m,
3H), 7.10–7.25 (m, 3H), 7.48 (d, 1H, J = 8.0 Hz); EIMS: m/z 330
(M), 299, 267, 196, 165, 141, 121, 69, 51, 43; IR (KBr) ν/cm1
3030, 2928, 2828, 1657, 1470, 1235, 1089, 1070, 1038, 905, 820,
750 [Calc. for C19H22O5 (330.378): C, 69.08; H, 6.71. Found: C,
70.13; H, 6.75%].
Compound 4o. 2-(3,4-Dimethoxyphenyl)-8-ethoxy-2,4-dimeth-
oxychromane. Liquid 1H NMR (CDCl3) δ 1.45 (t, 3H, J =
6.8 Hz), 1.83 (dd, 1H, J = 12.5, 10.7 Hz), 2.65 (dd, 1H, J = 12.5,
6.0 Hz), 3.15 (s, 3H), 3.48 (s, 3H), 3.90 (s, 6H), 4.18 (q, 2H, J =
6.8 Hz), 4.83 (dd, 1H, J = 10.7, 6.0 Hz), 6.83–6.98 (m, 3H),
7.10–7.20 (m, 2H), 7.58 (d, 1H, J = 8.1 Hz); EIMS: m/z 374
(M), 180, 165, 141, 137, 79, 69, 51, 43; IR (KBr) ν/cm1 3025,
2920, 2835, 1650, 1475, 1230, 1080, 1075, 1040, 902, 820, 740
[Calc. for C21H26O6 (374.43): C, 67.36; H, 7.0. Found: C, 67.38;
H, 7.05%].
III Molecular dynamics
Molecular dynamics calculations were carried out using Sybyl
6.7 program on a Silicon Graphics O2 work station. The Tripos
force field with default parameters was used throughout the
simulations. Minimizations were done first with steepest decent,
followed by conjugate gradient methods for a maximum of
1000 iterations each. A 20 psec MD run at 300 K temperature
was done and the conformations for each and every 500 fsec
were sampled. The collected conformations were minimized
using the above-mentioned procedure. Out of those 40 con-
formations one of the minimum-energy conformations which
was consistent with NOE studies has been shown in the paper.
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